EU rules are denying children latest cancer drugs
2/11/2014
Children with cancer are being denied new, potentially life-saving drugs, because EU rules are allowing companies to trial some drugs only in adults, leading cancer experts warn.
Smoking may increase the risk of the most common type of breast cancer
2/11/2014
Young women who smoke and have been smoking a pack a day for a decade or more have a significantly increased risk of developing the most common type of breast cancer. That is the finding of an analysis published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Statistical mechanics and mathematical modeling shed light on epigenetic memory
2/11/2014
A Lawrence Livermore National Laboratory physicist and his colleagues have found a new application for the tools and mathematics typically used in physics to help solve problems in biology.
A child's gender influences symptoms of genetic disorder
2/11/2014
A genetic disorder that affects about 1 in every 2,500 births can cause a bewildering array of clinical problems, including brain tumors, impaired vision, learning disabilities, behavioral problems, heart defects and bone deformities. The symptoms and their severity vary among patients affected by this condition, known as neurofibromatosis type 1 (NF1).
Discovery of global regulator of mRNA editing
2/11/2014
An international team of researchers, led by scientists from the University of California, San Diego School of Medicine and Indiana University, have identified a protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed and ultimately translated into the myriad of proteins necessary for life.
Discovery of global regulator of mRNA editing
2/11/2014
An international team of researchers, led by scientists from the University of California, San Diego School of Medicine and Indiana University, have identified a protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed and ultimately translated into the myriad of proteins necessary for life.
Vitamin C may boost chemotherapy
2/10/2014
A new study suggests giving some cancer patients high doses of vitamin C intravenously - as opposed to orally - alongside conventional chemotherapy, may help kill cancer cells and also reduce some of its toxic side effects.
Vitamin C may boost chemotherapy
2/10/2014
A new study suggests giving some cancer patients high doses of vitamin C intravenously - as opposed to orally - alongside conventional chemotherapy, may help kill cancer cells and also reduce some of its toxic side effects.
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die.
Septic shock is caused by excessive and systemic reaction of the entire body against infectious agents, in most cases of bacterial origin. The number of deaths by septic shock in intensive care units is very high and is still increasing, despite numerous large scale clinical trials.